ES504323A0 - Un procedimiento para la preparacion de un compuesto - Google Patents

Un procedimiento para la preparacion de un compuesto

Info

Publication number
ES504323A0
ES504323A0 ES504323A ES504323A ES504323A0 ES 504323 A0 ES504323 A0 ES 504323A0 ES 504323 A ES504323 A ES 504323A ES 504323 A ES504323 A ES 504323A ES 504323 A0 ES504323 A0 ES 504323A0
Authority
ES
Spain
Prior art keywords
procedure
compound
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES504323A
Other languages
English (en)
Spanish (es)
Other versions
ES8301926A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Pfizer Corp SRL
Original Assignee
Pfizer Corp Belgium
Pfizer Corp SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium, Pfizer Corp SRL filed Critical Pfizer Corp Belgium
Publication of ES8301926A1 publication Critical patent/ES8301926A1/es
Publication of ES504323A0 publication Critical patent/ES504323A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/233Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04Ortho- or peri-condensed ring systems
    • C07D221/06Ring systems of three rings
    • C07D221/10Aza-phenanthrenes
    • C07D221/12Phenanthridines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
ES504323A 1980-07-28 1981-07-27 Un procedimiento para la preparacion de un compuesto Granted ES504323A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/173,207 US4309545A (en) 1980-07-28 1980-07-28 Oximino-1-hydroxyoctahydrobenzo[c]quinolines and derivatives thereof

Publications (2)

Publication Number Publication Date
ES8301926A1 ES8301926A1 (es) 1982-12-16
ES504323A0 true ES504323A0 (es) 1982-12-16

Family

ID=22630983

Family Applications (1)

Application Number Title Priority Date Filing Date
ES504323A Granted ES504323A0 (es) 1980-07-28 1981-07-27 Un procedimiento para la preparacion de un compuesto

Country Status (29)

Country Link
US (1) US4309545A (OSRAM)
EP (1) EP0045171B1 (OSRAM)
JP (1) JPS57112372A (OSRAM)
KR (1) KR850000273B1 (OSRAM)
AR (1) AR230988A1 (OSRAM)
AT (1) ATE11775T1 (OSRAM)
AU (1) AU525944B2 (OSRAM)
CA (1) CA1178274A (OSRAM)
CS (1) CS228515B2 (OSRAM)
DD (1) DD202012A5 (OSRAM)
DE (1) DE3168891D1 (OSRAM)
DK (1) DK334581A (OSRAM)
EG (1) EG15535A (OSRAM)
ES (1) ES504323A0 (OSRAM)
FI (1) FI812338L (OSRAM)
GR (1) GR75283B (OSRAM)
GT (1) GT198170557A (OSRAM)
HU (1) HU185133B (OSRAM)
IE (1) IE51426B1 (OSRAM)
IL (1) IL63423A0 (OSRAM)
IN (1) IN158867B (OSRAM)
NO (2) NO812557L (OSRAM)
NZ (1) NZ197856A (OSRAM)
PH (1) PH17281A (OSRAM)
PL (1) PL133928B1 (OSRAM)
PT (1) PT73440B (OSRAM)
SU (1) SU1217254A3 (OSRAM)
YU (1) YU185181A (OSRAM)
ZA (1) ZA815128B (OSRAM)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4920221A (en) * 1982-03-16 1990-04-24 Pfizer Inc. Substituted decahydro-1H-pyrido[1,2-f]phenanthridines and decahydropyrrolo[1,2-f]phenanthridines
US4642373A (en) * 1982-03-16 1987-02-10 Pfizer Inc. Substituted dodecahydrotripheylenes, and decahydropyrrolo[1,2-f]phenanthridines as CNS agents
US4473704A (en) * 1982-03-16 1984-09-25 Pfizer Inc. Substituted dodecahydrotriphenylenes, decahydro-1H-cyclopenta[1]phenanthrenes, decahydro-1H-pyrido[1,2-f]phenanthridines and decahydropyrrolo[1,2-f]phenanthridines as CNS agents
US5605906A (en) * 1995-03-24 1997-02-25 Merck Frosst Canada, Inc. Cannabinoid receptor agonists
BR9707233A (pt) * 1996-01-31 1999-07-20 Byk Gulden Lomberg Chem Fab Fenantridinas
US6127378A (en) * 1996-03-26 2000-10-03 Byk Gulden Lomberg Chemische Fabrik Gmbh Phenanthridines substituted in the 6 position
EP0889886B1 (de) * 1996-03-26 2002-09-18 ALTANA Pharma AG Neue in 6-position substituierte phenanthridine
US5776482A (en) * 1996-03-29 1998-07-07 University Of Iowa Research Foundation Tetrahydroquinoline analogues for use in glaucoma treatment
AU756349B2 (en) * 1997-07-25 2003-01-09 Altana Pharma Ag Substituted 6-phenylphenanthridines
DE69808099T2 (de) * 1997-07-25 2003-05-15 Altana Pharma Ag Substituierte 6-alkylphenanthridine
CN1561990A (zh) 1999-03-22 2005-01-12 免疫力药品有限公司 治疗免疫疾病
US6566560B2 (en) 1999-03-22 2003-05-20 Immugen Pharmaceuticals, Inc. Resorcinolic compounds
US20060084021A1 (en) * 2004-09-10 2006-04-20 Kubicek Chris A Wick holder
AU2001296402A1 (en) * 2000-09-28 2002-04-08 Immugen Pharmaceuticals, Inc. Methods and compounds for inhibiting eicosanoid metabolism and platelet aggregation
US6541510B2 (en) * 2000-09-28 2003-04-01 Immugen Pharmaceuticals, Inc. Antiviral methods and compounds
US20030232101A1 (en) * 2002-03-18 2003-12-18 Immugen Pharmaceuticals, Inc. Topical formulations of resorcinols and cannibinoids and methods of use
AU2005247480A1 (en) * 2004-05-25 2005-12-08 Qlt Inc. Oculoselective drugs and prodrugs

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3839441A (en) * 1969-10-27 1974-10-01 Hoffmann La Roche Intermediates for partially hydrogenated phenanthridines
US3878219A (en) * 1973-07-13 1975-04-15 Abbott Lab 5H-{8 1{9 benzopyrano{8 3,4-d{9 pyridines
US3928598A (en) * 1973-11-05 1975-12-23 Lilly Co Eli Hexahydro-dibenzo{8 b,d{9 pyran-9-ones as an anti-anxiety drug
US4087545A (en) * 1976-02-17 1978-05-02 Eli Lilly And Company Hexahydro-dibenzo[b,d]pyran-9-ones as antiemetic drugs
SE7704749L (sv) * 1976-05-17 1977-12-05 Pfizer Kinoliner och forfarande och mellanprodukter for framstellning derav
HU180916B (hu) 1976-05-17 1983-05-30 Pfizer Eljárás benzo[c]kinolin-származékok előállítására
US4152450A (en) * 1978-02-17 1979-05-01 Eli Lilly And Company 9-Amino-dibenzopyrans

Also Published As

Publication number Publication date
EP0045171A2 (en) 1982-02-03
IN158867B (OSRAM) 1987-02-07
PL133928B1 (en) 1985-07-31
CS228515B2 (en) 1984-05-14
DK334581A (da) 1982-01-29
PT73440B (en) 1983-06-20
IE811686L (en) 1982-01-28
US4309545A (en) 1982-01-05
ES8301926A1 (es) 1982-12-16
JPS57112372A (en) 1982-07-13
PL232331A1 (en) 1983-09-26
DE3168891D1 (en) 1985-03-28
PH17281A (en) 1984-07-06
AU7343481A (en) 1982-05-06
SU1217254A3 (ru) 1986-03-07
KR850000273B1 (ko) 1985-03-15
DD202012A5 (de) 1983-08-24
AR230988A1 (es) 1984-08-31
NO854454L (no) 1985-01-29
ZA815128B (en) 1982-07-28
YU185181A (en) 1983-12-31
IL63423A0 (en) 1981-10-30
ATE11775T1 (de) 1985-02-15
EP0045171A3 (en) 1982-04-28
KR830006217A (ko) 1983-09-20
CA1178274A (en) 1984-11-20
FI812338A7 (fi) 1982-01-29
IE51426B1 (en) 1986-12-24
AU525944B2 (en) 1982-12-09
NZ197856A (en) 1984-10-19
FI812338L (fi) 1982-01-29
EG15535A (en) 1986-09-30
PT73440A (en) 1981-08-01
GR75283B (OSRAM) 1984-07-13
GT198170557A (es) 1983-01-12
EP0045171B1 (en) 1985-02-13
HU185133B (en) 1984-12-28
NO812557L (no) 1982-01-29

Similar Documents

Publication Publication Date Title
ES499079A0 (es) Un procedimiento para la preparacion de un compuesto
ES505517A0 (es) Un procedimiento para la preparacion de un derivado de n- arilbenzamida
ES499077A0 (es) Un procedimiento para la preparacion de nuevos compuestos antihipercolesteremicos
ES504103A0 (es) Un procedimiento para la preparacion de derivados de hidan- toina
ES502906A0 (es) Un procedimiento para la preparacion de nuevos derivados de imidazo-rifamicina
ES487381A0 (es) Un procedimiento para la preparacion de un compuesto de guanidinotiazol
ES505950A0 (es) Un procedimiento para la preparacion de un derivado de tia- zol
ES505678A0 (es) Un procedimiento para la preparacion de un derivado de 3- aril-5-isotiazol
ES506141A0 (es) Un procedimiento para la preparacion de piridin- y pira- cin-derivados
ES502994A0 (es) Un procedimiento para la preparacion de derivados de pirazo-lopiridacina
ES502792A0 (es) Un procedimiento para la preparacion de derivados de imida- zol
ES499559A0 (es) Un procedimiento para la preparacion de derivados de pirrol
ES498922A0 (es) Un procedimiento para la preparacion de compuestos de polie-ter antibioticos
ES504323A0 (es) Un procedimiento para la preparacion de un compuesto
ES534218A0 (es) Un procedimiento para la preparacion de compuestos de bencimidazol
ES492772A0 (es) Un procedimiento para la preparacion de un compuesto de ce- falosporina
ES504764A0 (es) Un procedimiento para la preparacion de un derivado 2-tiope-nem
ES492230A0 (es) Un procedimiento para la preparacion de nuevos derivados de carbostirilo
ES504376A0 (es) Un procedimiento para la preparacion de un derivado de fene-tilamina
ES505019A0 (es) Un procedimiento para la preparacion de compuestos
ES503565A0 (es) Un procedimiento para la preparacion de tilactona o un esterderivado de la misma
ES501232A0 (es) Un procedimiento para la preparacion de fenil-quinolicidinas
ES500911A0 (es) Un procedimiento para la preparacion de derivados de ergoli-na
ES499572A0 (es) Un procedimiento para la preparacion de nuevas guanilamidi- nas
ES498145A0 (es) Un procedimiento para la preparacion de derivados de metoxi-cefalosporinas